20062020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2006 2020

Filter
Letter
2020

Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis

Abbasi, A., Peeke, S., Shah, N., Mustafa, J., Khatun, F., Lombardo, A., Abreu, M., Elkind, R., Fehn, K., de Castro, A., Wang, Y., Derman, O., Nelson, R., Uehlinger, J., Gritsman, K., Sica, R. A., Kornblum, N., Mantzaris, I., Shastri, A., Janakiram, M. & 4 others, Goldfinger, M., Verma, A., Braunschweig, I. & Bachier-Rodriguez, L., Jan 3 2020, In : Journal of hematology & oncology. 13, 1, 1 p.

Research output: Contribution to journalLetter

Open Access
B-Cell Lymphoma
Cell- and Tissue-Based Therapy
Nervous System
Hepatitis
HIV
2019

Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis

Adrianzen Herrera, D., Pradhan, K., Snyder, R., Karanth, S., Janakiram, M., Mantzaris, I., Braunschweig, I., Budhathoki, A., Shah, U. A., Verma, A. K., Murthy, S. B. & Shastri, A., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

2018
3 Citations (Scopus)

Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease

Janakiram, M., Verma, A., Wang, Y., Budhathoki, A., Suarez Londono, J., Murakhovskaya, I., Braunschweig, I. & Minniti, C. P., Jan 2 2018, In : Leukemia and Lymphoma. 59, 1, p. 241-244 4 p.

Research output: Contribution to journalLetter

Hydroxyurea
Sickle Cell Anemia
Transplantation
2 Citations (Scopus)

Effect of hepatitis B and C infection on Recruitment for Cancer Clinical Trials

Janakiram, M., Jasra, S. & Aboulafia, D., Jan 1 2018, In : Journal of Clinical Oncology. 36, 10, p. 1047-1048 2 p.

Research output: Contribution to journalLetter

Hepatitis C
Hepatitis B
Clinical Trials
Infection
Neoplasms
33 Citations (Scopus)

Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy

Ratner, L., Waldmann, T. A., Janakiram, M. & Brammer, J. E., May 17 2018, In : New England Journal of Medicine. 378, 20, p. 1947-1948 2 p.

Research output: Contribution to journalLetter

Adult T Cell Leukemia Lymphoma
Therapeutics
2016
1 Citation (Scopus)

Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor

Assal, A., Dong, B., Khan, H., Medavarapu, R., Shastri, A., Pradhan, K., Friedman, E., Mantzaris, I., Janakiram, M., Battini, R., Kornblum, N., Yu, Y., Verma, A., Braunschweig, I. & Derman, O., Oct 2 2016, In : Leukemia and Lymphoma. 57, 10, p. 2452-2455 4 p.

Research output: Contribution to journalLetter

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
11 Citations (Scopus)

High prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS/AML cohort

Goel, S., Hall, J., Pradhan, K., Hirsch, C., Przychodzen, B., Shastri, A., Mantzaris, I., Janakiram, M., Battini, R., Kornblum, N., Derman, O., Gritsman, K., Al-Hafidh, J., Wang, Y., Halmos, B., Steidl, U., Maciejewski, J. P., Braunschweig, I. & Verma, A., Aug 1 2016, In : Leukemia. 30, 8, p. 1793-1795 3 p.

Research output: Contribution to journalLetter

Alleles
Mutation
5 Citations (Scopus)

Lenalidomide in the treatment of Rosai Dorfman disease-a first in use report

Rubinstein, M., Assal, A., Scherba, M., Elman, J., White, R., Verma, A., Strakhan, M., Mohammadi, F. & Janakiram, M., Feb 1 2016, In : American Journal of Hematology. 91, 2, p. E1

Research output: Contribution to journalLetter

Open Access
Sinus Histiocytosis
Thalidomide
Immunologic Factors
lenalidomide
2011

Acquired erythrocytosis upon treatment with infliximab for ankylosing spondylitis

Antonelli, M., Bupathi, M., Janakiram, M., Hergenroeder, P. & Khan, M. A., Mar 1 2011, In : Journal of Rheumatology. 38, 3, p. 581-583 3 p.

Research output: Contribution to journalLetter

Open Access
Janus Kinase 2
Polycythemia
Antirheumatic Agents
Ankylosing Spondylitis
Monoclonal Antibodies